Primary testicular tumours and management of clinical stage 1 testicular cancer

Abstract

Get full access to this article

View all access options for this article.

References

Chia

Quraishi

Devesa

. International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 2010; 19: 1151–1159.

Chowdhury

Rudman

Global incidence and outcome of testicular cancer. Clin Epidemiol 2013; 5: 417–427.

Ghazarian

Trabert

Devesa

. Recent trends in the incidence of testicular germ cell tumors in the United States. Andrology 2015; 3: 13–18.

Stenman

U-H

Alfthan

Hotakainen

Human chorionic gonadotropin in cancer. Clin Biochem 2004; 37: 549–561.

Silberstein

Bazzi

Vertosick

. Clinical outcomes of local and metastatic testicular sex cord-stromal tumors. J Urol 2014; 192: 415–419.

Manecksha

Fitzpatrick

JM.

Epidemiology of testicular cancer. BJU Int 2009; 104: 1329–1333.

Albers

Albrecht

Algaba

. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304–319.

Trabert

Chen

Devesa

. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007. Andrology 2015; 3: 4–12.

Chimento

Sirianni

Casaburi

. GPER signaling in spermatogenesis and testicular tumors. Front Endocrinol (Lausanne) 2014; 5: 30.

10.

Rajpert-De Meyts

. Developmental model for the pathogenesis of testicular carcinoma in situ: Genetic and environmental aspects. Hum Reprod Update 2006; 12: 303–323.

11.

Rapley

Hockley

Warren

. Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer 2004; 90: 2397–2401.

12.

Osterlind

Berthelsen

Abildgaard

. Risk of bilateral testicular germ cell cancer in Denmark: 1960–1984. J Natl Cancer Inst 1991; 83: 1391–1395.

13.

Richenberg

Belfield

Ramchandani

. Testicular microlithiasis imaging and follow-up: Guidelines of the ESUR scrotal imaging subcommittee. Eur Radiol 2015; 25: 323–330.

14.

Sharpe

RM.

The ‘oestrogen hypothesis’: Where do we stand now?

Int J Androl 2003; 26: 2–15.

15.

Chevalier

Bouskine

Fenichel

Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int J Cancer 2012; 130: 241–242.

16.

Vandenberg

Maffini

Sonnenschein

. Bisphenol-A and the great divide: A review of controversies in the field of endocrine disruption. Endocr Rev 2009; 30: 75–95.

17.

Douglas

Richardson

Nicol

DL.

Testicular germ cell tumors exhibit evidence of hormone dependence. Int J Cancer 2006; 118: 98–102.

18.

Carstairs

SD.

Diagnosis of testicular cancer with a urine pregnancy test in an austere military medical environment. Am J Emerg Med 2013; 31: 1615.

19.

Braunstein

Buster

Soares

. Pregnancy hormone concentrations in marijuana users. Life Sci 1983; 33: 195–199.

20.

Braunstein

Thompson

Gross

. Marijuana use does not spuriously elevate serum human chorionic gonadotropin levels. Urology 1985; 25: 605–606.

21.

Gottlieb

Oka

Sonography of the scrotum. Radiology 2003; 227: 18–36.

22.

Skoogh

Steineck

Cavallin-Ståhl

. Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: A population-based long-term follow-up of testicular cancer survivors. Int J Androl 2011; 34: 183–192.

23.

Robinson

Tait

Clarke

. Is it safe to insert a testicular prosthesis at the time of radical orchidectomy for testis cancer: An audit of 904 men undergoing radical orchidectomy. BJU Int 2016; 117: 249–252.

24.

Adshead

Khoubehi

Wood

. Testicular implants and patient satisfaction: A questionnaire-based study of men after orchidectomy for testicular cancer. 2001; 88: 559–562.

25.

Bodiwala

Summerton

Terry

TR.

Testicular prostheses: Development and modern usage. Ann R Coll Surg Engl 2007; 89: 349–353.

26.

Giannarini

Dieckmann

K-P

Albers

. Organ-sparing surgery for adult testicular tumours: A systematic review of the literature. Eur Urol 2010; 57: 780–790.

27.

Bazzi

Raheem

Stroup

. Partial orchiectomy and testis intratubular germ cell neoplasia: World literature review. Urol Ann 2011; 3: 115–118.

28.

Heidenreich

Weissbach

Höltl

. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001; 166: 2161–2165.

29.

Fraietta

Spaine

Bertolla

. Individual and seminal characteristics of patients with testicular germ cell tumors. Fertil Steril 2010; 94: 2107–2112.

30.

Royal Colleges of Physicians, Radiologists, and Obste-tricians and Gynaecologists. The effects of cancer treatment on reproductive functions: Guidance on management. Report of a working party, UK, November 2007.

31.

Gates

Oncology Nursing Secrets. 3rd ed. Elsevier Health Sciences, 2008. Mosby Elsevier: Maryland Heights, MS, US.

32.

Code of practice . 8th ed. Human Fertilisation and Embryology Authority (HFEA), 2015. pp128–139.

33.

Homerton University Hospital. Price list for self-funding NHS patients, http://www.homerton.nhs.uk/our-services/services-a-z/f/fertility-centre/price-lists/ (2014).

34.

Johnson

Cooper

Jungheim

. Sperm banking for fertility preservation: A 20-year experience. Eur J Obstet Gynecol Reprod Biol 2013; 170: 177–182.

35.

Williams

DH.

Sperm banking and the cancer patient. Ther Adv Urol 2010; 2: 19–34.

36.

Stephenson

Sheinfeld

The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urol Oncol 2004; 22: 225–233; discussion 234–235.

37.

Dalal

Sohaib

Huddart

Imaging of testicular germ cell tumours. Cancer Imaging 2006; 6: 124–134.

38.

Oldenburg

Aparicio

Beyer

. Personalizing, not patronizing: The case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Ann Oncol 2015; 26: 833–888.

39.

Kollmannsberger

Tandstad

Bedard

. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol . Epub ahead of print 18 August 2014. DOI: 10.1200/JCO.2014.56.2116.

40.

Cohn-Cedermark

Stahl

Tandstad

Surveillance vs. adjuvant therapy of clinical stage I testicular tumors: A review and the SWENOTECA experience. Andrology 2015; 3: 102–110.

41.

Shelley

Burgon

Mason

MD.

Treatment of testicular germ-cell cancer: A cochrane evidence-based systematic review. Cancer Treat Rev 2002; 28: 237–253.

42.

Aparicio

Maroto

García Del Muro

. Prognostic factors for relapse in stage I seminoma: A new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG). Ann Oncol 2014; 25: 2173–2178.

43.

Van den Belt-Dusebout

de Wit

Gietema

. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007; 25: 4370–4378.

44.

Albers

Albrecht

Algaba

. Guidelines on testicular cancer: 2015 update. Eur Urol 2015; 68: 1054–1068.

45.

Oliver

RTD

Mead

Rustin

GJS

. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol 2011; 29: 957–962.

46.

Dong

Liu

Z-W

X-D

. Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors. Med Oncol 2013; 30: 494.

47.

O’Sullivan

JM.

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol 2003; 14: 91–96.

48.

Singhera

Lees

Huddart

. Minimizing toxicity in early-stage testicular cancer treatment. Expert Rev Anticancer Ther 2012; 12: 185–193.

49.

Jacobsen

N-EB

Foster

Donohue

. Retroperitoneal lymph node dissection in testicular cancer. Surg Oncol Clin N Am 2007; 16: 199–220.

50.

Albers

Siener

Kliesch

. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: Results of the German Testicular Cancer Study Group Trial. J Clin Oncol 2003; 21: 1505–1512.

51.

Heinzelbecker

Gross-Weege

Weiss

. Microvascular invasion of testicular nonseminomatous germ cell tumors: Implications of separate evaluation of lymphatic and blood vessels. J Urol 2014; 192: 593–599.

52.

Albers

Siener

Krege

. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94. J Clin Oncol 2008; 26: 2966–2972.

53.

Acar

Gurocak

Sozen

Current treatment of testicular sex cord-stromal tumors: Critical review. Urology 2009; 73: 1165–1171.

54.

Van As

Gilbert

Money-Kyrle

. Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer 2008; 98: 1894–1902.